Resonate Blends, Inc. Seeks to Expand Its Product Development Roadmap

International Formulation Expert Colleen Quinn Joins The Company

CALABASAS, Calif.--(BUSINESS WIRE)--Resonate Blends, Inc. (OTCQB:KOAN), a Wellness Lifestyle cannabis holding company (“Resonate” or “the Company”), announced today it has retained the services of Colleen Quinn, an internationally celebrated clinical aromatherapist, cosmetic chemist, researcher and educator. Ms. Quinn specializes in cannabis research, formulations and education – and she will team with Resonate’s Director of Product, Skyler Quisenberry, to develop new cutting-edge cannabis plant-based products.

Ms. Quinn will also serve on the Company’s Advisory Board with a focus on cannabis product development and educational programs. She is an advocate of functional therapeutic plant-based products and has expertise in the chemistry of unique ingredient pairings which create new and enhanced synergistic impacts. The Koan family of brands is centered on innovative plant-based benefits, so the addition of Ms. Quinn is a major development for the enhancement of the Company’s product roadmap and the introduction of educational cannabis programs to both the retail and consumer channels throughout California.

Ms. Quinn began her career at the age of 20, studying aromatherapy in Provence, France and had her own complementary therapy practice for 10 years. During that time, she became a Macmillan-trained therapist, which led her to work with terminally ill cancer patients. Today, she has a particular interest in educating on the health benefits of essential oils and cannabis in the treatment of a wide array of conditions and particularly with oncology patients.

“It’s rare to find a brand and team with equal passion and precision as they strive to curate intellectual and mindful products to support their consumers in the many conquests our day to day lives present,” said Ms. Quinn. “Koan are creating experiences with their consumer at the center of all they design and deliver. I am delighted to work alongside such vehement minds.”

“Our mission as a Cannabis product company is to Master the Art of Experience. Everything we do is dedicated to that vision,” stated Resonate CEO Geoff Selzer. “Our first product, the Koan Cordials, currently rolling out to an enthusiastic industry response, is a perfect expression of that mission. Our going forward roadmap is deep and complex, and it took us a long time to find a person who could not only support our strategy but add to it in a significant way. Colleen is a professional with a great sense of excellence, discipline, education and perhaps most importantly, a refined sense of product to augment our own internal perspective. We are fortunate to someone of Colleen capability and passion as part of our team.”

Resonate Blends, Inc. (OTCQB:KOAN)

Resonate Blends is a Calabasas, CA-based portfolio of Cannabis Wellness and Lifestyle brands. The company created the Resonate System—a comprehensive system of interconnected experience targets to personalize consumers’ relationship with Cannabis through its products. www.resonateblends.com

Safe Harbor Provision:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Examples of forward-looking statements include, among others, statements we make regarding: guidance relating to net income; anticipated customer onboardings; and expected operating results, such as revenue growth and earnings. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the Company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set out in the Company's SEC filings. These risks and uncertainties could cause the Company's actual results to differ materially from those indicated in the forward-looking statements.